Short Answer
Complete Explanation
A heterogeneous marrow signal refers to an area of bone marrow on magnetic resonance imaging (MRI) that displays a mixture of signal intensities rather than a uniform appearance. This pattern may arise from differences in fat and water content, cellularity, or the presence of pathology such as infiltration, edema, or marrow reconversion. The appearance is evaluated on multiple pulse sequences (e.g., T1‑weighted, T2‑weighted, STIR) and correlated with the patient’s history, laboratory data, and other imaging findings to reach a diagnosis.
- Signal characteristics:
On T1‑weighted images, normal fatty marrow appears bright; heterogeneous signal may show areas of relative hypointensity (water‑rich) interspersed with hyperintense fat. - Common benign causes:
Age‑related marrow conversion, physiologic reconversion after anemia, or localized marrow edema from trauma. - Potential pathologic causes:
Infiltrative diseases (e.g., leukemia, lymphoma, metastatic cancer), infectious processes (osteomyelitis), or marrow‑replacing tumors. - Diagnostic approach:
Radiologists assess distribution (focal vs. diffuse), symmetry, associated cortical changes, and enhancement patterns after contrast administration. - Clinical relevance:
Identifying the cause guides further work‑up, which may include laboratory tests, biopsy, or follow‑up imaging.
Common Misconceptions
A heterogeneous signal always indicates cancer.
While it can be a sign of malignant infiltration, many benign conditions (e.g., age‑related conversion, marrow edema) produce similar appearances.
The finding is visible on plain X‑ray.
FAQ
What does a heterogeneous marrow signal indicate on MRI?
It indicates that the marrow within the evaluated bone segment has variable composition, which may be due to normal age‑related changes, benign processes like reconversion or edema, or pathologic conditions such as infection or neoplastic infiltration.
How can radiologists differentiate benign from malignant causes?
They consider factors such as the pattern (focal vs. diffuse), symmetry, associated cortical destruction, contrast enhancement, patient age, clinical history, and may recommend further testing like biopsy when imaging is inconclusive.
Is additional imaging always required when heterogeneous marrow signal is seen?
Not necessarily. If the finding aligns with a known benign cause and the patient has no concerning symptoms, observation may be sufficient. However, suspicious features often prompt further evaluation with targeted MRI sequences, CT, or laboratory studies.
Leave a Reply